drugset
drugset / Trial / NCT01430533

Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

NCT01430533 ↗

Phase 1 Completed 240 enrolled LEO Pharma Bayer · collab
RandomizedParallel-groupDouble-blindBasic science

Summary

The purpose of this study is to determine the dermal sensitization potential of azelaic acid pre-foam formulation.

Timeline

Start
2011-09
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Azelaic acid Small molecule — Topical

Indications

No indication recorded.